Global Study of Del-desiran for the Treatment of DM1

NCT06411288 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

DM1
Myotonic Dystrophy
Myotonic Dystrophy 1
Myotonia
Myotonic Dystrophy Type 1 (DM1)
Dystrophy Myotonic
Myotonic Disorders
Steinert Disease
Steinert
Myotonic Muscular Dystrophy

Interventions

DRUG: AOC 1001 (del-desiran)
DRUG: Placebo

Sponsor

Avidity Biosciences, Inc.